Hepatitis C Therapy - Legal blow in fight for hepatitis C inquiry

Legal blow in fight for hepatitis C inquiry
Scotsman - CAMPAIGNERS were dealt a blow yesterday in their fight for a public inquiry into why hundreds of people contracted hepatitis C through contaminated blood transfusions in the 1980s. A judge refused to break Scottish legal ground by protecting

Dynavax hepatitis vaccine shows promise
BusinessWeek - DEC. 19 9:09 A.M. ET Dynavax Technologies Corp., a biopharmaceutical focused on treatments for allergies, infectious and chronic inflammatory diseases, said Monday a mid-stage trial of its hepatitis B virus, or HBV, vaccine was successful, warranting

Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after
BioMed Central - This study used data from the United States Renal Data System (USRDS), using standard analysis files (SAF's) as of May 2000. The USRDS, indirectly mandated by federal law, incorporates baseline and follow-up demographic and clinical data on all